|
Volumn 56, Issue 2, 2010, Pages 83-89
|
[Add on lamivudine to adefovir monotherapy for the treatment of lamivudine-resistant chronic hepatitis B patients].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR;
ADENINE;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PHOSPHONIC ACID DERIVATIVE;
VIRUS DNA;
ADULT;
ANTIVIRAL RESISTANCE;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
FEMALE;
HEPATITIS B;
HUMAN;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
ADENINE;
ADULT;
ANTIVIRAL AGENTS;
DNA, VIRAL;
DRUG RESISTANCE, VIRAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS B E ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
LAMIVUDINE;
MALE;
MIDDLE AGED;
PHOSPHONIC ACIDS;
|
EID: 79952030753
PISSN: 15989992
EISSN: None
Source Type: Journal
DOI: 10.4166/kjg.2010.56.2.83 Document Type: Article |
Times cited : (3)
|
References (0)
|